DK3043810T3 - Immunsystemsmodulatorer - Google Patents

Immunsystemsmodulatorer Download PDF

Info

Publication number
DK3043810T3
DK3043810T3 DK14771713.6T DK14771713T DK3043810T3 DK 3043810 T3 DK3043810 T3 DK 3043810T3 DK 14771713 T DK14771713 T DK 14771713T DK 3043810 T3 DK3043810 T3 DK 3043810T3
Authority
DK
Denmark
Prior art keywords
immune system
system modulators
modulators
immune
Prior art date
Application number
DK14771713.6T
Other languages
Danish (da)
English (en)
Inventor
Leif Hakansson
Original Assignee
Canimguide Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canimguide Therapeutics Ab filed Critical Canimguide Therapeutics Ab
Application granted granted Critical
Publication of DK3043810T3 publication Critical patent/DK3043810T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14771713.6T 2013-09-09 2014-09-08 Immunsystemsmodulatorer DK3043810T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361875598P 2013-09-09 2013-09-09
PCT/US2014/054612 WO2015035332A1 (en) 2013-09-09 2014-09-08 Immune system modulators

Publications (1)

Publication Number Publication Date
DK3043810T3 true DK3043810T3 (da) 2020-01-27

Family

ID=51585229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14771713.6T DK3043810T3 (da) 2013-09-09 2014-09-08 Immunsystemsmodulatorer

Country Status (10)

Country Link
US (3) US9657059B2 (cg-RX-API-DMAC7.html)
EP (2) EP3656391A1 (cg-RX-API-DMAC7.html)
JP (2) JP6886816B2 (cg-RX-API-DMAC7.html)
KR (1) KR102162323B1 (cg-RX-API-DMAC7.html)
CN (2) CN105744944B (cg-RX-API-DMAC7.html)
AU (1) AU2014317884B2 (cg-RX-API-DMAC7.html)
CA (1) CA2923160A1 (cg-RX-API-DMAC7.html)
DK (1) DK3043810T3 (cg-RX-API-DMAC7.html)
ES (1) ES2777939T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015035332A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2608803T3 (es) 2007-05-08 2017-04-17 Canimguide Therapeutics Ab Estructuras inmunorreguladoras procedentes de proteínas naturales
CN105744944B (zh) 2013-09-09 2020-07-07 卡尼姆盖德治疗学公司 免疫系统调节器
ES2853582T3 (es) * 2015-03-06 2021-09-16 Canimguide Therapeutics Ab Moduladores del sistema inmune y composiciones
US9793852B2 (en) 2015-07-15 2017-10-17 Solarcity Corporation Clamp and bowl mounting system for photovoltaic modules
KR101896777B1 (ko) 2016-10-06 2018-09-07 현대자동차주식회사 내습성이 향상된 배리어 필름의 제조방법 및 이에 의해 제조된 배리어 필름
EP3856144A1 (en) 2018-09-28 2021-08-04 CanImGuide Therapeutics AB Pharmaceutical formulations of peptide inhibitors
JP7473565B2 (ja) 2019-01-28 2024-04-23 ミトコンドリア エモーション， インク． マイトフュージン活性化物質及びその使用方法
JP7734917B2 (ja) 2019-01-28 2025-09-08 ミトコンドリア エモーション， インク． トランス－４－ヒドロキシシクロヘキシルフェニルアミドマイトフュージン活性化物質及びその使用方法
CN111649776A (zh) * 2020-04-14 2020-09-11 东莞市创宏医疗科技有限公司 一种无屏检测系统
GB202211043D0 (en) * 2022-07-28 2022-09-14 Univ Birmingham Peptide agonist
KR20250040766A (ko) * 2023-09-15 2025-03-25 (주)케어젠 발모 촉진 및 탈모 억제 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US715368A (en) 1902-05-29 1902-12-09 Isaac N Graham Cutter-bar for harvesters or mowers.
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
JP3571337B2 (ja) 1992-02-11 2004-09-29 セル ジェネシス，インコーポレーテッド 遺伝子標的現象による同型遺伝子接合
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
IT1263831B (it) 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
SE502408C2 (sv) 1993-09-30 1995-10-16 Dataliner Ab Skalmönster vid lägesbestämning med hjälp av en snäv mätstråle
US5888767A (en) 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
EP1415982A1 (en) 1998-03-11 2004-05-06 G.D. SEARLE & CO. Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
AUPP616498A0 (en) 1998-09-25 1998-10-15 University Of Queensland, The Synthesis of cyclic peptides
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6703491B1 (en) * 1999-03-17 2004-03-09 Exelixis, Inc. Drosophila sequences
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
US6881719B2 (en) 2000-01-18 2005-04-19 Mcgill University β-turn peptidomimetic cyclic compounds
US6495674B1 (en) 2000-02-25 2002-12-17 The Salk Institute For Biological Studies Evectins and their use
US7252952B2 (en) 2000-03-06 2007-08-07 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein—protein interaction
US6417237B1 (en) 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
ATE409047T1 (de) * 2001-04-30 2008-10-15 Lilly Co Eli Humanisierte antikörper
KR100566911B1 (ko) 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7084257B2 (en) * 2001-10-05 2006-08-01 Amgen Inc. Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
ES2283759T3 (es) * 2002-01-18 2007-11-01 Pierre Fabre Medicament Anticuerpos anti-igf-ir y sus aplicaciones.
US7153685B2 (en) 2002-03-11 2006-12-26 The Board Of Trustees Of The University Of Illinois Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
WO2003099312A1 (en) * 2002-05-27 2003-12-04 Östergötlands Läns Landsting Method for determining immune system affecting compounds
EP1513879B1 (en) 2002-06-03 2018-08-22 Genentech, Inc. Synthetic antibody phage libraries
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
EP1539234A4 (en) 2002-09-05 2006-02-15 Medimmune Inc METHOD FOR PREVENTING OR TREATING CELL MALIGNITY BY ADMINISTERING CD2 ANTAGONISTS
US20090183270A1 (en) * 2002-10-02 2009-07-16 Adams Thomas R Transgenic plants with enhanced agronomic traits
US20040208921A1 (en) 2003-01-14 2004-10-21 Ho Rodney J. Y. Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues
CA2518956A1 (en) 2003-03-10 2004-09-23 Applera Corporation Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
WO2004087947A1 (en) 2003-03-31 2004-10-14 Mcmaster University Aptamer selection method
AU2003902875A0 (en) * 2003-06-10 2003-06-26 The University Of Melbourne Immunomodulating compositions, uses therefor and processes for their production
KR101531400B1 (ko) 2003-06-27 2015-06-26 암젠 프레몬트 인코포레이티드 상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그용도
RU2356909C2 (ru) 2003-11-13 2009-05-27 Ханми Фарм. Инд. Ко., Лтд. Белковый комплекс, полученный с использованием фрагмента иммуноглобулина, и способ получения такого комплекса
AU2005249490B2 (en) 2004-06-01 2010-07-29 Genentech, Inc. Antibody drug conjugates and methods
JP2008501360A (ja) 2004-06-11 2008-01-24 カソリック ユニバーシティー インダストリー アカデミー コオペレーション ファウンデーション ＣＥＡ−特異的な細胞毒性Ｔ細胞を生成する組み換えアデノウイルスＡｄＶＣＥＡで形質導入された樹枝状細胞、及びこれを含むワクチン並びに薬剤学的組成物
FR2873699B1 (fr) 2004-07-29 2009-08-21 Pierre Fabre Medicament Sa Nouveaux anticorps anti igf ir rt leurs utilisations
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
EP1875246B1 (en) 2005-04-15 2016-10-05 CanImGuide Therapeutics AB Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
US20090137736A1 (en) 2005-11-08 2009-05-28 Ambrx, Inc. Accelerants for the Modification of Non-Natural Amino Acids and Non-Natural Amino Acid Polypeptides
CN101448512B (zh) 2005-12-14 2015-11-25 Ambrx公司 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
AR057253A1 (es) * 2005-12-16 2007-11-21 Genentech Inc Anticuerpos anti-ox40l y metodos que los utilizan
WO2008112941A1 (en) 2007-03-13 2008-09-18 Board Of Regents The University Of Texas System Composition and method for the treatment of diseases affected by a peptide receptor
ES2608803T3 (es) 2007-05-08 2017-04-17 Canimguide Therapeutics Ab Estructuras inmunorreguladoras procedentes de proteínas naturales
WO2009047360A1 (en) 2007-10-11 2009-04-16 Novo Nordisk A/S Il-21 antibodies
RU2360924C1 (ru) * 2007-12-21 2009-07-10 Институт биохимии им. А.А. Баха РАН Маркер рака предстательной железы
EP2550529B1 (en) * 2010-03-23 2021-11-17 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
EP2715367A2 (en) * 2011-06-03 2014-04-09 University of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
CN105744944B (zh) 2013-09-09 2020-07-07 卡尼姆盖德治疗学公司 免疫系统调节器
ES2853582T3 (es) 2015-03-06 2021-09-16 Canimguide Therapeutics Ab Moduladores del sistema inmune y composiciones

Also Published As

Publication number Publication date
CA2923160A1 (en) 2015-03-12
EP3656391A1 (en) 2020-05-27
US20170298096A1 (en) 2017-10-19
WO2015035332A1 (en) 2015-03-12
CN111732652A (zh) 2020-10-02
US10301356B2 (en) 2019-05-28
KR102162323B1 (ko) 2020-10-06
US20190375789A1 (en) 2019-12-12
CN105744944B (zh) 2020-07-07
JP2020019803A (ja) 2020-02-06
JP6886816B2 (ja) 2021-06-16
US9657059B2 (en) 2017-05-23
US20160311854A1 (en) 2016-10-27
KR20160054531A (ko) 2016-05-16
EP3043810B1 (en) 2019-10-23
AU2014317884B2 (en) 2017-09-07
JP2016531583A (ja) 2016-10-13
ES2777939T3 (es) 2020-08-06
EP3043810A1 (en) 2016-07-20
CN105744944A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
EP3463216A4 (en) ANTI-SABOTAGE SYSTEM
DK3848027T3 (da) Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer
PL3003919T3 (pl) System realizacji zamówień
FI20135538A7 (fi) Hissijärjestelmä
DK3004155T3 (da) Peptidforbindelse
FI20136147A7 (fi) Hissijärjestelmä
PL2996514T3 (pl) Układ przesuwny
HRP20182004T1 (hr) Tetrahidropiridopirazini modulatori gpr6
EP2964120A4 (en) ILIAKALVERBINDER
EP2999699A4 (en) PURINE DIONES AS MODULATORS OF THE WNT PATH
HUE042285T2 (hu) Bemenet lezáró rendszer
DK3043810T3 (da) Immunsystemsmodulatorer
DE112014004622A5 (de) Mikroreaktorsystem
EP2982408A4 (en) INTERCONNECTS
DK3007564T3 (da) Struktureret fedtsystem
DK3017139T3 (da) Undersøisk interventionssystem
DE112014004683A5 (de) Ausfallsicheres Kamerasystem
DE112014004954T8 (de) Abgabesystem
DK2826742T3 (da) Elevator system
FI10285U1 (fi) Pysäköintijärjestelmä
DE112014004938T8 (de) Abgabesystem
DK3074978T3 (da) Interaktivt mediesystem
EP3017500C0 (en) RADAR SYSTEM
EP2979762A4 (en) Isolator system
DK3904699T3 (da) Hydrauliksystem